期刊文献+

Wnt/β-catenin信号通路在非小细胞肺癌中作用的研究进展 被引量:2

Progress in the role of Wnt/β-catenin signaling in non-small cell lung cancer
下载PDF
导出
摘要 Wnt/β-catenin信号通路在胚胎发育和细胞增殖、分化等生理过程中扮演着重要角色,同时它在非小细胞肺癌(non-small cell lung cancer, NSCLC)的肿瘤干细胞(cancerstemcell, CSCs)的维持、血管生成和上皮间充质转化(epithelial-mesenchymaltransition, EMT)中起着至关重要的作用。有多项研究证实Wnt/β-catenin信号通路在NSCLC中被显著激活,随着对Wnt/β-catenin信号通路的研究,靶向Wnt/β-catenin信号通路疗法在NSCLC的治疗中取得了显著成效。本文对Wnt/β-catenin信号通路在NSCLC发生和发展中的作用以及治疗研究进行概述。 Wnt/β-catenin signaling pathway plays an important role in embryonic development and cell proliferation,differentiation,and other physiological processes.It also plays a crucial role in the maintenance of cancer stem cells(CSCs),angiogenesis and epithelial-mesenchymal transition(EMT)in non-small cell lung cancer(NSCLC).Several studies have confirmed that Wnt/β-catenin signaling pathway is significantly activated in NSCLC.With the study of Wnt/β-catenin signaling pathway,targeted Wnt/β-catenin signaling pathway therapy has achieved remarkable results in the treatment of NSCLC.This article reviews the role and treatment of Wnt/β-catenin signaling pathway in the occurrence and development of NSCLC.
作者 沈齐 张玲芳 胡翰 汪洋 刘滨磊 SHEN Qi;ZHANG Lingfang;HU Han;WANG Yang;LIU Binlei(Faculty of Bioengineering and Food,Hubei University of Technology,Hubei Wuhan 430068,China;Wuhan Binhui Biotechnology Company Limited,Hubei Wuhan 436030,China)
出处 《现代肿瘤医学》 CAS 2024年第3期577-583,共7页 Journal of Modern Oncology
基金 国家自然科学基金青年基金项目(编号:82001758)。
关键词 非小细胞肺癌 WNT/Β-CATENIN信号通路 靶向治疗 肿瘤免疫 non-small cell lung cancer Wnt/β-catenin signaling pathway targeted therapy tumor immunity
  • 相关文献

参考文献3

二级参考文献37

  • 1Chandra P. Prasad,Sameer Mirza,Gayatri Sharma,Rajinder Prashad,Siddhartha DattaGupta,Gayatri Rath,Ranju Ralhan.Epigenetic alterations of CDH1 and APC genes: Relationship with activation of Wnt/β-catenin Pathway in invasive ductal carcinoma of breast[J]. Life Sciences . 2008 (9)
  • 2Nelson WJ,Nusse R.Convergence of Wnt, beta-catenin, and cadherin pathways. Science . 2004
  • 3Abcyrathna P,Su Y.The critical role of Akt in cardiovascular function. Vasrul Pharmacol . 2015
  • 4Abéngozar María Angeles,de Frutos Sergio,Ferreiro Sergio,Soriano Joaquím,Perez-Martinez Manuel,Olmeda David,Marenchino Marco,Ca?amero Marta,Ortega Sagrario,Megias Diego,Rodriguez Antonio,Martínez-Torrecuadrada Jorge L.Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growth. Blood . 2012
  • 5Roque Diaz,Paul A. Nguewa,Miriam Redrado,Irene Manrique,Alfonso Calvo.??Sunitinib reduces tumor hypoxia and angiogenesis, and radiosensitizes prostate cancer stem‐like cells(J)Prostate . 2015 (11)
  • 6Eswarappa SM,Fox PL.Antiangiogenic VEGF-Ax:A new participant in tumor angiogenesis. Cancer Research . 2015
  • 7Masri Bernard,van den Berghe Lo?c,Sorli Caroline,Knibiehler Bernard,Audigier Yves.(Apelin signalisation and vascular physiopathology)Journal de la Société de biologie . 2009
  • 8Casanovas Oriol.Cancer: Limitations of therapies exposed. Nature . 2012
  • 9Sarah J. Conley,Elizabeth Gheordunescu,Pramod Kakarala.Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia. Proceedings of the National Academy of Sciences of the United States of America . 2012
  • 10Hurwitz HI,Douglas PS,Middleton JP,et al.Analysis of early hypertension and clinical outcome with bevacizumab:results from seven phaseⅢstudies. The Oncologist . 2013

共引文献17

同被引文献9

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部